Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos

Blood

Volumn 112, Issue 5, 2008, Pages 1720-1729

  Trindade, Alexandre ^a,b   Kumar, S Ram ^c   Scehnet, Jeffrey S ^c   Lopes Da costa, Luis ^a   Becker, Jorg ^b   Jiang, Weidong ^d   Liu, Ren ^d   Gill, Parkash S ^c,e   Duarte, Antonio ^a,b  

^a INSTITUTO SUPERIOR DE AGRONOMIA   (Portugal)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Vasgene Therapeutics   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; NOTCH RECEPTOR; PROTEIN DLL4; UNCLASSIFIED DRUG; VASCULOTROPIN; DLL4 PROTEIN, HUMAN; DLL4 PROTEIN, MOUSE; MEMBRANE PROTEIN; SIGNAL PEPTIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; ANIMAL; ARTERY; CELL CULTURE; CELL MOTION; CONGENITAL MALFORMATION; CYTOLOGY; EMBRYO DEATH; ENDOTHELIUM CELL; FETUS HEART; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; GESTATIONAL AGE; HUMAN; MALE; PHENOTYPE; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; TRANSGENIC MOUSE; VEIN;

ANIMALS; ARTERIES; CELL MOVEMENT; CELLS, CULTURED; EMBRYO LOSS; EMBRYONIC DEVELOPMENT; ENDOTHELIAL CELLS; FEMALE; FETAL HEART; GENE DOSAGE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GESTATIONAL AGE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; PREGNANCY; RECEPTORS, NOTCH; TRANSFECTION; VEINS;

EID: 52649121738     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-09-112748     Document Type: Article

References (44)

1. Wang HU, Chen ZF, Anderson DJ. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 1998;93:741-753.
2. Gerety SS, Wang HU, Chen ZF, Anderson DJ. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell. 1999;4:403-414.
3. Adams RH, Wilkinson GA, Weiss C, et al. Roles of ephrin B ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 1999;13: 295-306.
4. Gale NW, Baluk P, Pan L, et al. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol. 2001;230:151-160.
5. Krebs LT, Xue Y, Norton CR, et al. Notch signaling is essential tor vascular morphogenesis in mice. Genes Dev. 2000;14:1343-1352.
6. Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D, Kitajewski J. Notch4/int-3, a mammary proto-oncogene, is an endothelial cellspecific mammalian Notch gene. Development. 1996;122:2251-2259.
7. Shutter JR, Scully S, Fan W, et al. DII4, a novel Notch ligand expressed in arterial endothelium. Genes Dev. 2000;14:1313-1318.
8. Lawson ND, Vogel AM, Weinstein BM. sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell. 2002;3:127-136.
9. Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 2004; 18:901-911.
10. Duarte A, Hirashima M, Benedito R, et al. Dosage-sensitive requirement for mouse DII4 in artery development. Genes Dev. 2004;18:2474-2478.
11. Sakai K, Miyazaki J. Atransgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem Biophys Res Commun. 1997;237: 318-324.
12. NovakA, Guo C, Yang W, Nagy A, Lobe CG. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis. 2000;28: 147-155.
13. Hogan B, Beddington R, Constantini F, Lacy E. Manipulating the mouse embryo. A laboratory manual (2nd ed). Woodbury, NY: Cold Spring Harbor Laboratory Press; 1994.
14. Akeson AL, Greenberg JM, Cameron JE, et al. Temporal and spatial regulation of VEGF-A controls vascular patterning in the embryonic lung. Dev Biol. 2003;264:443-455.
15. Henrique D, Hirsinger E, Adam J, et al. Maintenance of neuroepithelial progenitor cells by DeltaNotch signalling in the embryonic chick retina. Curr Biol. 1997;7:661-670.
16. Dunwoodie SL, Henrique D, Harrison SM, Beddington RS. Mouse DII3: a novel divergent Delta gene which may complement the function of other Delta homologues during early pattern formation in the mouse embryo. Development. 1997;124:3065-3076.
17. Scehnet JS, Jiang W, Kumar SR, et al. Inhibition of DII4 mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 2007;109:4753-4760.
18. Williams CK, Li JL, Murga M. Harris AL, Tosato G. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood. 2006;107:931-939.
19. Gu C, Yoshida Y Livet J, et al. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science. 2005;307:265-268.
20. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial celllineage analysis in vivo. Dev Biol. 2001;230:230-242.
21. Gustafsson E, Brakebusch C, Hietanen K, Fassler R. Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice. J Cell Sci. 2001;114:671-676.
22. MotoikeT Markham DW, Rossant J, Sato TN. Evidence for novel fate of Flk1 + progenitor: Contribution to muscle lineage. Genesis. 2003;35: 153-159.
23. Steidl C, Leimeister C, Klamt B, et al. Characterization of the human and mouse HEY1, HEY2. and HEYL genes: cloning, mapping, and mutation screening of a new bHLH gene family. Genomics. 2000:66:195-203.
24. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001;49:507-521.
25. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta. 2000; 1477:267-283.
26. Liu ZJ, Shirakawa T, Li Y, et al. Regulation of Notchl and DII4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol. 2003;23:14-25.
27. Gory-Faure S, Prandini MH, Pointu H, et al. Role of vascular endothelial-cadherin in vascular morphogenesis. Development. 1999;126:2093-2102.
28. Suchting S, Bicknell R, Eichmann A. Neuronal clues to vascular guidance. Exp Cell Res. 2006; 312:668-675.
29. Bedell VM, Yeo SY Park KW, et al. roundabout4 is essential for angiogenesis in vivo. Proc Natl Acad Sci U S A. 2005;102:6373-6378.
30. Lu X, Le Noble F, Yuan L, et al. The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature. 2004;432:179-186.
31. Sorensen LK, Brooke BS, Li DY, Urness LD. Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. Dev Biol. 2003;261:235-250.
32. Coultas L, Chawengsaksophak K, Rossant J. Endothelial cells and VEGF in vascular development. Nature. 2005;438:937-945.
33. Rossant J, Hirashima M. Vascular development and patterning: making the right choices. Curr Opin Genet Dev. 2003;13:408-412.
34. Hellstrom M, Phng LK, Hofmann JJ, et al. DII4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature. 2007;445: 776-780.
35. Lobov IB, Renard RA, Papadopoulos N, et al. Delta-like ligand 4 (DII4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci U S A. 2007;104:3219-3224.
36. Suchting S, Freitas C, le Noble F et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci U S A. 2007;104:3225-3230.
37. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res. 2000;60:203-212.
38. Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci U S A. 1998;95:9349-9354.
39. Hiratsuka S, Nakao K, Nakamura K, Katsuki M, Maru Y, Shibuya M. Membrane fixation of vascular endothelial growth factor receptor 1 ligandbinding domain is important for vasculogenesis and angiogenesis in mice. Mol Cell Biol. 2005;25: 346-354.
40. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92:735-745.
41. Noguera-Troise I, Daly C, Papadopoulos NJ, et al. Blockade of DII4 inhibits tumour growth by promoting non-productive angiogenesis. Nature. 2006;444:1032-1037.
42. Ridgway J, Zhang G, Wu Y, et al. Inhibition of DII4 signalling inhibits tumour growth by deregulating angiogenesis. Nature. 2006;444:1083-1087.
43. Leslie JD, Ariza-McNaughton L, BermangeAL, McAdow R, Johnson SL, Lewis J. Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development. 2007;134:839-844.
44. Siekmann AF, Lawson ND. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature. 2007;445:781-784.